{Reference Type}: Journal Article
{Title}: Pituitary Complications of Checkpoint Inhibitor Use.
{Author}: Chamorro-Pareja N;Faje AT;Miller KK;
{Journal}: Endocrinology
{Volume}: 165
{Issue}: 9
{Year}: 2024 Jul 26
{Factor}: 5.051
{DOI}: 10.1210/endocr/bqae084
{Abstract}: Immune checkpoint inhibitors have revolutionized cancer therapy but are associated with a risk of endocrine immune-related adverse events, including pituitary complications. Autoimmune hypophysitis, traditionally a rare diagnosis, has become a more frequently encountered clinical entity with the emergence of antitumor immunotherapy. This mini-review aims to consolidate current knowledge, encompassing the epidemiology, pathophysiology, clinical presentation, diagnosis, and management of pituitary complications of immune checkpoint inhibitor use.